Pharmacogenomics - Health Technology Insights

Cullinan, Taiho Present Zipalertinib Phase 2b Results at ASCO 2025

May 26, 2025

England’s NICE recommends FILSPARI as a treatment option for IgA nephropathy

May 23, 2025

PEMGARDA Added to NCCN Guidelines for B-Cell Lymphomas

May 23, 2025

UniXell Doses First Patient with UX-DA001 for Parkinson’s disease

May 23, 2025

Jill Thompson and Harold Kisner Join CLEU Diagnostics Advisory Board

FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi

May 19, 2025

Moleculin Gets EMA Approval to Expand Phase 3 MIRACLE Trial

Moleculin Gets EMA Approval to Expand Phase 3 MIRACLE Trial

May 12, 2025

Mayo Clinic Uses Phenomix AI to Predict GLP-1 Side Effects

Mayo Clinic Uses Phenomix AI to Predict GLP-1 Side Effects

May 8, 2025

Knight Therapeutics Announces Relaunch of ONICIT in Brazil and Mexico

Knight Therapeutics Announces Relaunch of ONICIT in Brazil and Mexico

May 7, 2025

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi

CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi

April 29, 2025

Alcyone Secures Funding to Advance Pediatric Neuro Therapies

Alcyone Secures Funding to Advance Pediatric Neuro Therapies

April 24, 2025

Recent Posts

How Mobile-First Patient Support Will Define the Next Generation of Telehealth

How Mobile-First Patient Support Will Define the Next Generation of Telehealth

Tevogen Unveils Tevogen.AI: AI-Powered Immunotherapy with Microsoft and Databricks

Sun Pharma Completes its Acquisition of Checkpoint Therapeutics

Real-World Deployments Signal AI Healthcare Is Ready for Scale

Isotopia and Cardirad Launch Isoprotrace in Sweden and Denmark for Prostate Cancer Imaging

BioCryst Shows ORLADEYO Cuts HAE Attacks Across All Age Groups

Fuel up with free Health Tech Insights